Drug Claim Sorting Hierarchy for Medicare Adjudication Accuracy
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The implementation of Medicare Part D introduced complex rules for drug claim processing, but lacked specific lists or rules necessary for automated sorting and adjudication in production environments, leading to inefficiencies and errors in claims processing.
Innovation Solution
A system that automatically sorts and processes drug claims by matching them against a hierarchy of processed drug lists, including Medicare Part B, Part D, infusion drugs, and other categories, using a series of determinations to route claims accurately and efficiently according to CMS guidelines, with the ability to update lists periodically based on CMS information and pharmacist expertise.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Device complexity
If automated claims processing is implemented without specific drug lists, then system complexity is reduced, but processing accuracy and reliability deteriorate
Solution Approach 1:
The patent applies preliminary action by pre-processing and maintaining updated drug lists that categorize medications according to CMS guidelines before claims processing occurs. These pre-prepared lists include Medicare Part B drugs, Part D drugs, infusion drugs, and other categorized medications, enabling accurate automated sorting without requiring complex real-time decision logic during claim processing.
2Reliability
If manual drug claim sorting is used, then processing accuracy is maintained, but productivity and speed of processing deteriorate
Solution Approach 1:
The patent implements self-service by enabling the system to automatically sort and route claims against preprocessed drug lists without human intervention. The automated claim sort engine compares claim medications against the pre-categorized drug lists and automatically routes claims to appropriate processing queues, maintaining both accuracy and high processing speed simultaneously.
3Adaptability or versatility
If drug lists are updated frequently based on CMS changes, then adaptability to new regulations is improved, but system stability and processing consistency deteriorate
Solution Approach 1:
The patent applies preliminary action by maintaining pre-processed drug lists that are updated in advance of claims processing. When CMS releases new guidelines or drug categorizations, the lists are updated beforehand and made available to the claim sorting system, ensuring consistent and stable processing while maintaining adaptability to regulatory changes.
4Reliability
If comprehensive drug categorization lists are maintained, then processing accuracy is improved, but device complexity and data management requirements deteriorate
Solution Approach 1:
The patent applies segmentation by dividing the comprehensive drug classification system into distinct, manageable categories including Medicare Part B drugs, Medicare Part D drugs, infusion drugs, and other specialized categories. Each category is maintained as a separate pre-processed list, simplifying data management while enabling accurate claim routing through systematic comparison against these segmented categories.
Data Source
AI summary
A method of processing drug claims, by: (a) receiving a claim; (b) sorting the claim for processing by determining which processed drug list the claim belongs with; and then (c) processing the claim according to the particular processed drug list to which the claim belongs. A hierarchy of drug lists are used in a preferred order. If the drug is found on the first drug list, the system then moves directly to the processing stage. However, if the drug is not found on the first list, the system checks whether the drug is on the second drug list. If the drug is found on the second drug list, the system then moves directly to the processing stage, etc. Preferably, the drug list hierarchy is as follows: (i) home infusion drug list; (ii) drug only listed as a Medicare Part B drug list; (iii) drug listed as either Medicare Part B or D drug list; (iv) required special class drug list; (v) nebulized drug list; (vi) over the counter drug list; (vii) Medicare statutorily excluded non-Part D drug list; (viii) enhanced benefit system drug list; (ix) Medicare Part D or Medicare Part D covered under an enhanced benefit drug list, and (x) a vaccine drug list.